在心力衰竭中使用远程护理技术的患者偏好:离散选择实验
Ahmed Al-Naher1, Jennifer Downing2, Dyfrig Hughes1,3
1Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, United Kingdom.
JMIR cardio
|November 5, 2025
概括
患有心力衰竭的患者更喜欢远程护理技术,优先考虑临床护理而不是沟通. 了解这些偏好可以改善与远程健康监测解决方案的参与.
科学领域:
- 医疗信息学 医疗信息学
- 患者参与 患者参与
- 慢性疾病管理 慢性疾病管理
背景情况:
- 远程护理技术对于弥合医疗保健差距至关重要,特别是在COVID后.
- 患有慢性疾病的患者可以从持续监测和自我管理支持中受益.
- 与远程护理技术的低参与度阻碍了资源投资和护理质量.
研究的目的:
- 在心力衰竭中确定患者对远程护理技术的偏好.
- 建立一个影响远程护理参与的因素等级.
- 为未来远程护理技术的设计提供信息,以便更好地接受患者.
主要方法:
- 设计了一个离散选择实验调查,并得到了患者的意见.
- 调查包括代表沟通,临床护理,教育,易用性和便利性的属性.
- 在线分发给心力衰竭患者,使用二进制逻辑回归分析.
主要成果:
- 临床护理 (系数2.022) 是最喜欢的属性.
- 教育 (1.252),便利性 (1.245) 和易用性 (1.155) 也是重要的因素.
- 在研究的因素中,沟通 (1.040) 是最不喜欢的属性.
结论:
- 在远程技术设计中优先考虑临床护理,为患者参与提供了最大的潜力.
- 了解患者的偏好是最大限度地发挥心力衰竭管理远程护理的好处的关键.
- 设计人员可以利用偏好权重来提高远程护理解决方案的感知价值和采用率.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


